New studies are fueling optimism about GLP-1's potential role in prevention and treatment of breast, colon and lung cancer
19
votes
Showing only topics with the tag "glp 1".
Back to normal view
-
-
There may not be a safe off-ramp for some taking GLP-1 drugs, study suggests
22 votes -
Obesity rate declining in US. Use of GLP-1 injectables for weight loss has more than doubled since early 2024.
28 votes -
Half of people on weight loss drugs quit within one year, Danish study finds – more likely to stop taking the drugs if they were younger, lived in poorer areas, or were men
24 votes -
Novo Nordisk shares plunge 20% after Wegovy maker names new CEO and cuts full-year guidance
10 votes -
Novo Nordisk's ad campaign, which aimed to speak ‘without filters’ by declaring obesity a disease, has faced strong criticism on social media and from some scientific societies
21 votes -
Novo Nordisk CEO Lars Fruergaard Jørgensen steps down amid growing competition for weight loss drugs
11 votes -
Eleven spouses on what it’s like to live with someone on Ozempic
36 votes -
As revolutionary new weight-loss drugs turn consumers off ultraprocessed foods, the industry is on the hunt for new products
20 votes -
The GLP-1 compounding loophole
24 votes -
The growing scientific case for using Ozempic and other GLP-1s to treat opioid, alcohol, and nicotine addiction
39 votes -
Most patients using weight-loss drugs like Wegovy stop within a year, data show
10 votes